InflaRx had been pursuing development of vilobelimab in other indications beyond COVID, but the company’s hopes for the asset ...

Competition in the obesity treatment market has intensified, and it is rapidly shifting from being centered on pharmaceutical companies to focusing on patients and consumers.” Mike Durstdar, the new ...

Focusing on 2026 as a starting point, PwC has laid out several “strategic imperatives” pharma companies ought to pursue this ...

In 2025, made or projected biopharma workforce cuts affected about 42,700 employees, according to BioSpace tallies. BioSpace ...

James Foster’s legendary half-century run at Charles River Laboratories is coming to an end. After more than 30 years as ...

Navigating the Future of Technology and Business" report, identifying 10 trends that will define the next era of enterprise technology. Based on extensive conversations with industry experts ...

Good morning. Generic semaglutide is now legal in Canada, putting Ozempic on the brink of a price reset – more on that below, along with Chrystia Freeland’s last day as an MP and the drop in ...

Calm moves for Wall Street overall are masking big gains underneath the surface for makers of weapons and other military ...

Stock indexes are drifting in early trading, masking some big gains underneath the surface for makers of weapons and other ...